» Articles » PMID: 37249983

Probiotics Therapy Show Significant Improvement in Obesity and Neurobehavioral Disorders Symptoms

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a complex metabolic disease, with cognitive impairment being an essential complication. Gut microbiota differs markedly between individuals with and without obesity. The microbial-gut-brain axis is an important pathway through which metabolic factors, such as obesity, affect the brain. Probiotics have been shown to alleviate symptoms associated with obesity and neurobehavioral disorders. In this review, we evaluated previously published studies on the effectiveness of probiotic interventions in reducing cognitive impairment, depression, and anxiety associated with obesity or a high-fat diet. Most of the probiotics studied have beneficial health effects on obesity-induced cognitive impairment and anxiety. They positively affect immune regulation, the hypothalamic-pituitary-adrenal axis, hippocampal function, intestinal mucosa protection, and glucolipid metabolism regulation. Probiotics can influence changes in the composition of the gut microbiota and the ratio between various flora. However, probiotics should be used with caution, particularly in healthy individuals. Future research should further explore the mechanisms underlying the gut-brain axis, obesity, and cognitive function while overcoming the significant variation in study design and high risk of bias in the current evidence.

Citing Articles

Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults.

Florencio G, Xavier A, Natal A, Sadoyama L, Roder D, Menezes R Metabolites. 2025; 15(2).

PMID: 39997695 PMC: 11857521. DOI: 10.3390/metabo15020070.


Mechanism of Action and Beneficial Effects of Probiotics in Amateur and Professional Athletes.

Nami Y, Barghi A, Shahgolzari M, Salehian M, Haghshenas B Food Sci Nutr. 2025; 13(1):e4658.

PMID: 39803224 PMC: 11717059. DOI: 10.1002/fsn3.4658.


Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review.

Yarahmadi A, Afkhami H, Javadi A, Kashfi M Diabetol Metab Syndr. 2024; 16(1):308.

PMID: 39710683 PMC: 11664868. DOI: 10.1186/s13098-024-01561-z.


Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an Model of Intestinal Epithelial Barrier Dysfunction.

Tinazzi M, Sacilotto A, Cocetta V, Giacomini I, Raso F, Bulferi G Yale J Biol Med. 2024; 97(3):297-308.

PMID: 39351327 PMC: 11426300. DOI: 10.59249/JOMF5336.


Strain-specific effects of probiotics on depression and anxiety: a meta-analysis.

Rahmannia M, Poudineh M, Mirzaei R, Aalipour M, Shahidi Bonjar A, Goudarzi M Gut Pathog. 2024; 16(1):46.

PMID: 39245752 PMC: 11382490. DOI: 10.1186/s13099-024-00634-8.


References
1.
Anand S, Friedrich M, Lee D, Awadalla P, Despres J, Desai D . Evaluation of Adiposity and Cognitive Function in Adults. JAMA Netw Open. 2022; 5(2):e2146324. PMC: 8808326. DOI: 10.1001/jamanetworkopen.2021.46324. View

2.
Agusti A, Garcia-Pardo M, Lopez-Almela I, Campillo I, Maes M, Romani-Perez M . Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function. Front Neurosci. 2018; 12:155. PMC: 5864897. DOI: 10.3389/fnins.2018.00155. View

3.
Zhang Y, Huang B, Yang W, Zhong S, Lai S, Zhao H . Correlations Between Endocrine Hormones and Cognitive Function in Patients with Obesity: a Cross-sectional Study. Obes Surg. 2022; 32(7):2299-2308. DOI: 10.1007/s11695-022-06076-y. View

4.
Azad M, Sarker M, Li T, Yin J . Probiotic Species in the Modulation of Gut Microbiota: An Overview. Biomed Res Int. 2018; 2018:9478630. PMC: 5964481. DOI: 10.1155/2018/9478630. View

5.
Nagpal R, Neth B, Wang S, Craft S, Yadav H . Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019; 47:529-542. PMC: 6796564. DOI: 10.1016/j.ebiom.2019.08.032. View